课题基金 / 基金详情

Fundamental advancement of knowledge of Plasmodium vivax biology, drug susceptibility and transmission

Fundamental advancement of knowledge of Plasmodium vivax biology, drug susceptibility and transmission
间日疟原虫生物学、药物敏感性和传播知识的根本进步
批准号:
nhmrc : 1052760
负责人:
Dr Stephan Karl
金额:
$21.08万
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31

项目摘要

项目成果

Dr Stephan Karl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Plasmodium vivax is the most widespread malaria parasite causing over 80 million cases per year. Yet, current means to counter this parasite are grossly inadequate. Vast knowledge gaps exist due to unavailability of continuous cultures, high throughput drug assays and the poor understanding of transmission. This inhibits the development of new treatments for P. vivax. This project will fundamentally advance knowledge of the biology and epidemiology of this important, but neglected pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unravelling Plasmodium vivax transmission to Anopheles mosquitoes: Role of naturally acquired transmission blocking immunity and efficacy of novel vaccine and drug candidates
  • 批准号:
    nhmrc : 1141441
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $29.14万
  • 财政年份:
    2018
  • 负责人:
    Dr Stephan Karl
  • 依托单位:
Unravelling Plasmodium vivax transmission to Anopheles mosquitoes: Role of naturally acquired transmission blocking immunity and efficacy of novel vaccine and drug candidates
  • 批准号:
    nhmrc : GNT1141441
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $43.1万
  • 财政年份:
    2018
  • 负责人:
    Dr Stephan Karl
  • 依托单位:
Field-based evaluation of a novel magneto-optical technique to diagnose malaria
海外基金